ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts.

N V Rajeshkumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.